39
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Identifying the Prevalence and Correlates of Ecstasy and Other Club Drug (EOCD) Use Among High School Seniors

, &
Pages 53-66 | Received 08 Oct 2002, Accepted 10 Jan 2003, Published online: 25 Sep 2008
 

Abstract

A plethora of anecdotal evidence has suggested that the use of “club drugs,” such as lysergic acid diethylamide (LSD), Ketamine, Gamma hydroxybutyrate (GHB), and 3,4-methylenedioxy-methamphe-tamine (MDMA or “ecstasy”), is a serious problem among youth across the United States. Unfortunately, little scientific evidence exists to support this contention. In the current study, we examine the ecstasy and other club drug (EOCD)-using behaviors of 1,561 high school seniors surveyed in 2000 through the Monitoring the Future (MTF) study. Prevalence estimates of EOCD use are generated and associations between EOCD use, demographic characteristics, and alcohol and other drug (AOD) use are explored. Twelve-month self-reports for ecstasy, LSD, Ketamine, and GHB were 8%, 6%, 2%, and 1%, respectively. Compared to students who reported no use of EOCD during the 12 months preceding the interview, 12-month EOCD users were significantly more likely to be white, to live in the suburbs, and to have used allother drugs of abuse during the 12 months preceding the interview. Logistic regression identified that the strongest predictors of 12-month EOCD use were the use of heroin and other psychedelic drugs during the 12 months preceding the interview. Implications for these findings are discussed.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.